Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  690 results for ""Antineoplastic Agents, Immunological""

Your Filters

Subject : skin neoplasms
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study.

  • Authors : Mortier L; Université Lille, CHRU Lille, 42 Rue Paul Duez, Lille, France. .; Villabona L

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: American journal of clinical dermatology [Am J Clin Dermatol] 2024 Nov; Vol. 25 (6), pp. 987-996. Date of Electronic Publication: 2024 Oct 08.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/pathology

  • Source: The Journal of dermatology [J Dermatol] 2024 Nov; Vol. 51 (11), pp. 1500-1503. Date of Electronic Publication: 2024 Apr 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial.

  • Authors : Eggermont AM; Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig Maximilians University, Munich, Germany; Princess Máxima Center and University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/pathology ; Melanoma*/Melanoma*/Melanoma*/mortality

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 211, pp. 114327. Date of Electronic Publication: 2024 Sep 12.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis.

  • Authors : Nardone V; Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy. Electronic address: .; Napolitano S

Subjects: Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/pathology ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/drug therapy ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/mortality

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Oct; Vol. 91 (4), pp. 678-683. Date of Electronic Publication: 2024 Jun 15.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

Read More Add to Saved list
×
Academic Journal

Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma.

  • Authors : Strum S; Department of Oncology, Division of Medical Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.; London Regional Cancer Program, London Health Sciences Centre, Victoria Hospital, London, ON, Canada.

Subjects: Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/drug therapy ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/pathology ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/mortality

  • Source: Journal of cutaneous medicine and surgery [J Cutan Med Surg] 2024 Sep-Oct; Vol. 28 (5), pp. 453-457. Date of Electronic Publication: 2024 Jul 26.Publisher: Sage Publications Country of Publication: United States NLM ID: 9614685 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Advanced cutaneous squamous cell carcinoma: Impact of age on the safety and efficacy of cemiplimab and the prognostic significance of blood biomarkers.

  • Authors : Ksienski D; BC Cancer-Victoria, British Columbia, Canada; University of British Columbia, Victoria, British Columbia, Canada. Electronic address: .

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/drug therapy

  • Source: Journal of geriatric oncology [J Geriatr Oncol] 2024 Jun; Vol. 15 (5), pp. 101789. Date of Electronic Publication: 2024 May 05.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma.

  • Authors : Yokota K; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Takenouchi T

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/mortality ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: The Journal of dermatology [J Dermatol] 2024 May; Vol. 51 (5), pp. 632-642. Date of Electronic Publication: 2024 Mar 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Response With Pembrolizumab for Cutaneous Squamous Cell Carcinoma.

  • Authors : Corbett M; University College Dublin Head and Neck Oncology Group, Dublin, Ireland.; Tohani S

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/therapeutic use ; Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/drug therapy

  • Source: JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2024 Jun 01; Vol. 150 (6), pp. 524-525.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589542 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study.

  • Authors : Luke JJ; UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA.; Ascierto PA

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/mortality ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 10; Vol. 42 (14), pp. 1619-1624. Date of Electronic Publication: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

A case of ruptured hepatic metastases during pembrolizumab administration for cutaneous malignant melanoma.

  • Authors : Igari S; Department of Dermatology, Fukushima Medical University, Fukushima, Japan. Electronic address: .; Yamamoto M

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Melanoma*/Melanoma*/Melanoma*/drug therapy

  • Source: Anais brasileiros de dermatologia [An Bras Dermatol] 2024 May-Jun; Vol. 99 (3), pp. 450-451. Date of Electronic Publication: 2024 Feb 01.Publisher: Elsevier España, S.L Country of Publication: Spain NLM ID: 0067662 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  690 results for ""Antineoplastic Agents, Immunological""